Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function
European Radiology · 2022-03 · 32 (3) · 1879-1890
DOI: 10.1007/s00330-021-08229-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, online erschienen am 22.09.2021. Verfasst von Marilisa Schiwek und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Subdivision of Pulmonary Imaging, University Hospital of Heidelberg, Im Neuenheimer Feld 420, …. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Heidelberg.
Themen: COPD
Abstract (Originalsprache)
Objectives
Pulmonary perfusion abnormalities are prevalent in patients with chronic obstructive pulmonary disease (COPD), are potentially reversible, and may be associated with emphysema development. Therefore, we aimed to evaluate the clinical meaningfulness of perfusion defects in percent (QDP) using DCE-MRI.
Methods
We investigated a subset of baseline DCE-MRIs, paired inspiratory/expiratory CTs, and pulmonary function testing (PFT) of 83 subjects (age = 65.7 ± 9.0 years, patients-at-risk, and all GOLD groups) from one center of the “COSYCONET” COPD cohort. QDP was computed from DCE-MRI using an in-house developed quantification pipeline, including four different approaches: Otsu’s method, k-means clustering, texture analysis, and 80 th percentile threshold. QDP was compared with visual MRI perfusion scoring, CT parametric response mapping (PRM) indices of emphysema (PRM Emph ) and functional small airway disease (PRM fSAD ), and FEV1/FVC from PFT.
Results
All QDP approaches showed high correlations with the MRI perfusion score ( r = 0.67 to 0.72, p < 0.001), with the highest association based on Otsu’s method ( r = 0.72, p < 0.001). QDP correlated significantly with all PRM indices ( p < 0.001), with the strongest correlations with PRM Emph ( r = 0.70 to 0.75, p < 0.001). QDP was distinctly higher than PRM Emph (mean difference = 35.85 to 40.40) and PRM fSAD (mean difference = 15.12 to 19.68), but in close agreement when combining both PRM indices (mean difference = 1.47 to 6.03) for all QDP approaches. QDP correlated moderately with FEV1/FVC ( r = − 0.54 to − 0.41, p < 0.001).
Conclusion
QDP is associated with established markers of disease severity and the extent corresponds to the CT-derived combined extent of PRM Emph and PRM fSAD . We propose to use QDP based on Otsu’s method for future clinical studies in COPD. Key Points • QDP quantified from DCE-MRI is associated with visual MRI perfusion score, CT PRM indices, and PFT. • The extent of QDP from DCE-MRI corresponds to the combined extent of PRM Emph and PRM fSAD from CT. • Assessing pulmonary perfusion abnormalities using DCE-MRI with QDP improved the correlations with CT PRM indices and PFT compared to the quantification of pulmonary blood flow and volume.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic and Interventional Radiology, Subdivision of Pulmonary Imaging, University Hospital of Heidelberg, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.
- Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397, Biberach an der Riß, Germany.
- Translational Lung Research Center Heidelberg (TLRC), German Lung Research Center (DZL), Im Neuenheimer Feld 156, 69120, Heidelberg, Germany.
- Faculty of Medicine, University of Latvia, Raina bulvaris 19, Riga, 1586, Latvia.
- Faculty of Medicine, Christian-Albrechts-Universität Zu Kiel, 24098, Kiel, Germany.
- Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik at the University Hospital of Heidelberg, Röntgenstr. 1, 69126, Heidelberg, Germany.
Förderung
- Universitätsklinikum Heidelberg
Zitieren
APA
Schiwek, M., Triphan, S. M. F., Biederer, J., Weinheimer, O., Eichinger, M., Vogelmeier, C. F., Jörres, R. A., Kauczor, H. U., Heußel, C. P., Konietzke, P., von Stackelberg, O., Risse, F., Jobst, B. J., Wielpütz, M. O., & COSYCONET study group (2022). Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function. European Radiology, 32(3), 1879-1890. https://doi.org/10.1007/s00330-021-08229-6
Vancouver
Schiwek M, Triphan SMF, Biederer J, Weinheimer O, Eichinger M, Vogelmeier CF, et al. Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function. European Radiology. 2022;32(3):1879-1890. doi:10.1007/s00330-021-08229-6
BibTeX
@article{Schiwek2022,
author = {Schiwek, Marilisa and Triphan, Simon M F and Biederer, Jürgen and Weinheimer, Oliver and Eichinger, Monika and Vogelmeier, Claus F and Jörres, Rudolf A and Kauczor, Hans-Ulrich and Heußel, Claus P and Konietzke, Philip and von Stackelberg, Oyunbileg and Risse, Frank and Jobst, Bertram J and Wielpütz, Mark O and COSYCONET study group, COSYCONET study group},
title = {Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function},
journal = {European Radiology},
year = {2022},
volume = {32},
number = {3},
pages = {1879--1890},
doi = {10.1007/s00330-021-08229-6}
}
EUVIMED